Last reviewed · How we verify
Generic Escitalopram
At a glance
| Generic name | Generic Escitalopram |
|---|---|
| Also known as | Generic Escitalopram Oxalate Tablet |
| Sponsor | Shanghai Mental Health Center |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Double-Blind Treatment of Major Depressive Disorder With Vilazodone (PHASE2)
- Comparison of Fluoxetine Versus Citalopram Therapy to Control Postmenopausal Vasomotor Syndrome (NA)
- Seroquel Alone Versus Seroquel With an SSRI for Depression With Psychotic Symptoms (PHASE4)
- Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder (PHASE2)
- A Clinical Trial to Evaluate the Efficacy and Safety of Generic Escitalopram in Depression (PHASE2, PHASE3)
- A Study Comparing Duloxetine to Other Antidepressants in the Treatment of Severe Depression (PHASE4)
- Comparison of the Pharmacokinetics of Two Generic Antidepressants and Their Respective Brand Preparations (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Generic Escitalopram CI brief — competitive landscape report
- Generic Escitalopram updates RSS · CI watch RSS
- Shanghai Mental Health Center portfolio CI